News | Radiation Oncology | July 17, 2019

ASTRO issues statement emphasizing need for radiation oncologists to participate in value-based cancer care

CMS Proposes New Alternative Payment Model for Radiation Oncology

July 17, 2019 — The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM) for radiation oncology on July 10, 2019. In response, the American Society for Radiation Oncology (ASTRO) issued the following statement from Paul Harari, M.D., FASTRO, chair of the ASTRO Board of Directors:

“The Radiation Oncology (RO) Model announced today by the Center for Medicare and Medicaid Innovation (Innovation Center) is a step forward in allowing the nation’s 4,500 radiation oncologists to participate in the transition to value-based care that improves outcomes for cancer patients. We believe that once implemented with modifications, the model will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure,” Harari said.

“We look forward to providing comments on the specifics of the model, including requirements for certain radiation oncology groups to participate. In our comments to CMS, ASTRO will prioritize recommendations that achieve our longstanding payment reform goals, including stable and fair payments accompanied by incentives for higher quality care and lower costs. In addition, ASTRO will look closely for opportunities to ensure the model is consistent with the administration’s initiative to reduce physician burden and paperwork,” he continued.

“ASTRO has worked for many years to craft a viable payment model that would stabilize payments, drive adherence to nationally-recognized clinical guidelines and improve patient care. We appreciate the Administration’s focus and commitment to ensuring radiation oncologists' ability to participate in an advanced APM,” Harari concluded. 

Read the full proposed alternative payment model from CMS.

For more information: www.astro.org

Related Content

News | Proton Therapy

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
News | Radiation Oncology

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Radiation Therapy

June 23, 2022 — RaySearch Laboratories AB announced the release of the latest version of RayCare*, the next generation ...

Time June 23, 2022
arrow
News | Artificial Intelligence

June 22, 2022 — Gradient Health, a medical technology company based in North Carolina, announced a new initiative which ...

Time June 22, 2022
arrow
News | SNMMI

June 22, 2022 — The Society of Nuclear Medicine and Molecular Imaging recognized 15 new SNMMI Fellows on Monday, June 13 ...

Time June 22, 2022
arrow
News | SNMMI

June 21, 2022 — Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, instructor and clinical coordinator at the ...

Time June 20, 2022
arrow
News | SIR

June 20, 2022 — SIR Foundation launched a program to enhance the scientific rigor of research into interventional ...

Time June 20, 2022
arrow
News | Interventional Radiology

June 17, 2022 — Parag J. Patel, MD, MS, FSIR, an interventional radiologist and professor of radiology at the Medical ...

Time June 17, 2022
arrow
News | Radiation Therapy

June 17, 2022 — Accuray Incorporated and Limbus AI Inc. announced they are partnering to augment Accuray adaptive ...

Time June 17, 2022
arrow
Subscribe Now